USE OF 4-[(4-N,N-DIETHYLAMINOCARBONYL)-PHENYL]-SPIRO[5-HYDROXY-2H,1-BENZOPYRAN-2,4'-PIPERIDINE] , OR 4-[(4-N,N-DIETHYLAMINOCARBONYL-2-HYDROXY)PHENYL]-SPIRO[2H,1-BENZOPYRAN-2,4'-PIPERIDINE] IN THE PREPARATION OF A MEDICAMENT FOR INHIBITING OR TREATING PAIN
Spirocyclic heterocyclic derivatives, pharmaceutical compositions containing these compounds, and methods for their pharmaceutical use are disclosed. In certain embodiments, the spirocyclic heterocyclic derivatives are ligands of the &delta； opioid receptor and may be useful, inter alia, for treating and/or preventing pain, anxiety, gastrointestinal disorders, and other &delta； opioid receptor-mediated conditions.
